Novakand Pharma AB (publ) (STO:NOVKAN)
0.1268
+0.0022 (1.77%)
Feb 11, 2026, 11:54 AM CET
-87.92% (1Y)
| Market Cap | 15.10M -87.9% |
| Revenue (ttm) | n/a |
| Net Income | -51.90M |
| EPS | -0.43 |
| Shares Out | 121.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 125,114 |
| Average Volume | 565,566 |
| Open | 0.1248 |
| Previous Close | 0.1246 |
| Day's Range | 0.1248 - 0.1296 |
| 52-Week Range | 0.0800 - 2.2500 |
| Beta | 1.02 |
| RSI | 44.57 |
| Earnings Date | Feb 20, 2026 |